Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05596760 · ClinicalTrials.gov registry record · NA
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
A NA study of Alzheimer Disease and Dementia, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 1,800
- Enrollment target
- 3
- Study locations
NCT05596760: Recruiting NA study of Alzheimer Disease and Dementia, sponsored by University of Washington.
NCT05596760 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by University of Washington. The registered enrollment target is 1,800 participants, below the 2,745-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (34% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05596760, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,800 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to improve communication among clinicians, patients with memory problems, and their family members. We are testing a way to help clinicians have better conversations to address patients' goals for their healthcare. To do this, we created a simple, short guide called the "Jumpstart Guide." The goal of this research study is to show that using this kind of guide is possible and can be helpful for patients and their families. Patients' clinicians may receive a Jumpstart Guide before the patient's clinic visit. Researchers will compare patients whose clinician received a Jumpstart Guide to patients whose clinician did not receive a guide to see if more patients in the Jumpstart Guide group had conversations about the patient's goals for their healthcare. Patients and their family members will also be asked to complete surveys after the visit with their clinician.
Primary Outcome
The primary outcome is the proportion of patients who have a goals-of-care discussion that has been documented in the EHR in the period by 90 days following randomization. The proportion is the number of patients with GOC documentation over the number of patients in each study arm.
Conditions Studied
Interventions
- BEHAVIORAL Jumpstart Guide
Study Locations (3)
Washington
- Harborview Medical Center - Seattle
- UW Medical Center - Seattle
- UW Medicine Neighborhood Clinics - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,800 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2027-07 |
| Phase | NA |
What NCT05596760 shows while recruiting
NCT05596760 is an interventional study that assigns participants to a tested intervention. Its 1,800 participants enrollment target places it among the larger protocols in the corpus, below the 2,745-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (34% lower).
The record links to 10 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Jumpstart Guide is the first listed.
NCT05596760 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05596760 about?
NCT05596760 is a clinical study titled "Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers". The goal of this clinical trial is to improve communication among clinicians, patients with memory problems, and their family members. We are testing a way to help clinicians have better conversations to address patients' goals for their healthcare. To do this, we created a simple, short guide calle...
What is the current status of trial NCT05596760?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,800 participants. The study started on 2023-09-11. Estimated completion is 2027-07.
What conditions does trial NCT05596760 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Cognitive Dysfunction, Huntington Disease, Dementia, Vascular.
What interventions are being tested in trial NCT05596760?
The interventions under investigation include: Jumpstart Guide (BEHAVIORAL).
Who is sponsoring clinical trial NCT05596760?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05596760 being conducted?
This trial has 3 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05596760's enrollment target sits among peer trials
1,800 22nd of 306 higher than 284 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
- NCT05258656 · 1,800 participants · NA
Childhood Activities Nutrition and Development Oversight
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI